Experimental CAR T-Cell therapy takes on progressive MS
Disease control
Ongoing
This early-stage trial tests a new treatment called KYV-101 for people with progressive multiple sclerosis (MS) that hasn't improved with standard treatments. KYV-101 is a CAR T-cell therapy made from a patient's own immune cells, designed to attack the cells causing inflammation…
Phase: PHASE1 • Sponsor: Bruce Cree • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC